Literature DB >> 12507568

Tissue chamber model of acute inflammation in farm animal species.

P Sidhu1, F Shojaee Aliabadi, M Andrews, P Lees.   

Abstract

A tissue chamber model of acute inflammation for use in comparative studies in calves, sheep, goats and pigs has been established and validated. Tissue chambers were prepared from silicon rubber tubing, of inner diameter 12.7 mm, length 115 mm and volume 15 ml, with 10 holes, each of 6mm diameter, at each end. In each animal two or four chambers were inserted at subcutaneous sites. Six weeks after implantation an acute inflammatory reaction in a single cage was generated by the intracaveal injection of 0.5 ml of 1% carrageenan solution. Serial samples of exudate (injected chamber), transudate (non-injected chamber) and blood were collected for measurement of exudate and transudate leucocyte count, prostaglandin (PG)E(2) concentration in exudate and serum thromboxane (Tx)B(2) concentration. In addition, skin temperature changes over exudate and transudate chambers were recorded. In all four species, carrageenan induced an acute inflammatory response, indicated by increases to peak values followed by return towards baseline in skin temperature, leucocyte count and PGE(2) concentration. For each of these variables in calves, sheep and goats the increases were significantly greater for exudate than for transudate. The degree of intra-species variation in each variable was acceptable. Marked inter-species differences were recorded: skin temperature rise was greatest in calves and least in sheep and goats; exudate PGE(2) concentration was increased in the order sheep>goat>pig>calf; serum TxB(2) concentration was increased in the order calf>goat>sheep>pig and exudate leucocyte count was increased to a greater extent in the pig than in the three ruminant species. The model has advantages over some previously described tissue chamber models of inflammation and will be suitable for use in comparative studies of inflammatory mechanisms and the pharmacokinetics and pharmacodynamics of anti-inflammatory drugs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12507568     DOI: 10.1016/s0034-5288(02)00149-2

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  6 in total

1.  Pharmacology of drugs used to treat osteoarthritis in veterinary practice.

Authors:  Peter Lees
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

Review 2.  Microdialysis: current applications in clinical pharmacokinetic studies and its potential role in the future.

Authors:  Christian Joukhadar; Markus Müller
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Response of a clinical Escherichia coli strain to repeated cefquinome exposure in a piglet tissue-cage model.

Authors:  Mengxiao Gu; Nan Zhang; Longfei Zhang; Mingpeng Xiong; Yuanyuan Yang; Xiaoyan Gu; Xiangguang Shen; Huanzhong Ding
Journal:  BMC Vet Res       Date:  2015-07-25       Impact factor: 2.741

4.  In vivo evaluation of mutant selection window of cefquinome against Escherichia coli in piglet tissue-cage model.

Authors:  Bingxu Zhang; Xiaoyan Gu; Yafei Li; Xiaohong Li; Mengxiao Gu; Nan Zhang; Xiangguang Shen; Huanzhong Ding
Journal:  BMC Vet Res       Date:  2014-12-16       Impact factor: 2.741

5.  Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against Pasteurella multocida in a Porcine Tissue Cage Model.

Authors:  Qiaoyi Zhou; Guijun Zhang; Qin Wang; Wenguang Liu; Yan Huang; Pengling Yu; Yanqin Li; Huanzhong Ding; Binghu Fang
Journal:  Front Pharmacol       Date:  2017-06-28       Impact factor: 5.810

6.  The Surface Area to Volume Ratio Changes the Pharmacokinetic and Pharmacodynamic Parameters in the Subcutaneous Tissue Cage Model: As Illustrated by Carprofen in Sheep.

Authors:  Richard Munn; Ted Whittem; Andrew P Woodward
Journal:  Front Vet Sci       Date:  2022-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.